Instability and variability of urinary telopeptides and free crosslinks

Clinica Chimica Acta

Volumn 324, Issue 1-2, 2002, Pages 73-79

  Schober, Edward A ^a   Breusch, Steffen J ^a   Schneider, Ulrich ^b,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Creatinine; Dpd; NTx; Stability; Storage; Variability

Indexed keywords

COLLAGEN TYPE 1; EPITOPE; PEPTIDE;

ADULT; AGED; ARTICLE; CENTRIFUGE; CLINICAL ARTICLE; CREATININE URINE LEVEL; CROSS LINKING; DENATURATION; FEMALE; HUMAN; MALE; PARTICLE RESUSPENSION; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; STORAGE; URINARY TRACT;

AGED; BIOLOGICAL MARKERS; BONE RESORPTION; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TEMPERATURE;

EID: 0036774094     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00208-5     Document Type: Article

References (47)

1. Christiansen C., Hassager C., Riis B.J. Biochemical markers of bone turnover. Avioli L.V., Krane S.M. Metabolic bone disease. 1998;313-326 Academic Press, New York.
2. Robins S.P. Collagen crosslinks in metabolic bone disease. Acta Orthop. Scand. 66(Suppl. 266):1995;171-175.
3. Knott L., Bailey A.J. Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone. 22:1998;181-187.
4. Seibel M.J., Baylink D.J., Farley J.R., Epstein S., Yamauchi M., Eastell R.et al. Basic science and clinical utility of biochemical markers of bone turnover - a congress report. Exp. Clin. Endocrinol. Diabetes. 105:1997;125-133.
5. Fujimoto S., Kubo T., Tanaka H., Miura M., Seino Y. Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiencies. J. Clin. Endocrinol. Metab. 80:1995;1922-1928.
6. Withold W., Friedrich W., Reinauer H. Comparison of biochemical markers of bone resorption in patients with metabolic and malignant bone diseases. Ann. Clin. Biochem. 33:1996;421-427.
7. Seibel M.J., Duncan A., Robins S.P. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J. Rheumatol. 16:1989;964-970.
8. Garnero P., Shih W.J., Gineyts E., Karpf D.B., Delmas P.D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to aldendronate treatment. J. Clin. Endocrinol. Metab. 79:1994;1693-1700.
9. Robins S.P., Seibel M.J. Biochemical markers of bone metabolism: a critical evaluation. Clin. Lab. 41:1995;987-989.
10. Black D., Duncan A., Robins S.P. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal. Biochem. 169:1988;197-203.
11. Delmas P.D., Schlemmer A., Gineyts E., Riis B., Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J. Bone Miner. Res. 6:1991;639-644.
12. Hanson D.A., Weis M.A., Bollen A.M., Maslan S.L., Singer F.R., Eyre D.R. A specific immunoassay for monitoring human bone resorption: quantitation of human type I collagen cross-linked collagen n-telopeptides in urine. J. Bone Miner. Res. 7:1992;1251-1258.
13. Eastell R., Colwell A., Hampton L., Reeve J. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J. Bone Miner. Res. 12:1997;59-65.
14. Schneider U., Breusch S.J., Kasperk C., Termath S., Thomsen M., Brocai D.R.C.et al. Increased urinary crosslink levels in aseptic loosening of total hip arthroplasty. J. Arthroplast. 13:1998;1-6.
15. Beck Jensen J.-E., Kollerup G., Sørensen H.A., Sørensen O.H. Intraindividual variability in bone markers in the urine. Scand. J. Clin. Lab. Invest. 57(Suppl. 227):1997;29-34.
16. Schlemmer A., Hassager C., Jensen S.B., Christiansen C. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J. Clin. Endocrinol. Metab. 74:1992;476-480.
17. Colwell A., Russell R.G.G., Eastell R. Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen markers of bone resorption. Eur. J. Clin. Invest. 23:1993;341-349.
18. Douglas A.S., Miller M.H., Reid D.M., Hutchison J.D., Porter R.W., Robins S.P. Seasonal differences in biochemical paramenters of bone remodelling. J. Clin. Pathol. 49:1996;284-289.
19. Ju H.-S.J., Leung S., Brown B., Stringer M.A., Leigh S., Scherrer C.et al. Comparison of analytical performance and biological variability of three bone resorption assays. Clin. Chem. 43:1997;1570-1576.
20. Eyre D.R., Dickson I.R., van Ness K.P. Collagen cross-linking in human bone and articular cartilage: age-related changes in the content of mature hydroxypyridinium residues. Biochem. J. 252:1988;495-500.
21. Beardsworth L.J., Eyre D.R., Dickson I.R. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J. Bone Miner. Res. 5:1990;671-676.
22. McLaren A.M., Isdale A.H., Whitings P.H., Bird H.A., Robins S.P. Physiological variation in the urinary excretion of pyridinium crosslinks of collagen. Br. J. Rheumatol. 32:1993;307-312.
23. Salamone L.M., Glynn N., Black D., Epstein R.S., Palermo L., Meilahn E.et al. Body composition and bone mineral density in premenopausal and early perimenopausal women. J. Bone Miner. Res. 10:1995;1762-1768.
24. Hannon R.A., Blumsohn A., Naylor K., Eastell R. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J. Bone Miner. Res. 13:1998;1124-1133.
25. Seibel M.J., Woitge H.W., Farahmand I., Oberwittler H., Ziegler R. Automated and manual assays for urinary crosslinks of collagen: which assay to use? Exp. Clin. Endocrinol. Diabetes. 106:1998;143-148.
26. Blumsohn A., Colwell A., Naylor K., Eastell R. Effect of light and γ-irradiation on pyridinolines and telopeptides of type I collagen in urine. Clin. Chem. 41:1995;1195-1197.
27. Walne A.J., James I.T., Perret D. The stability of pyridinium crosslinks in urine and serum. Clin. Chim. Acta. 240:1995;95-97.
28. Gerrits M.I., Thijssen J.H.H., van Rijn H.J.M. Determination of pyridinoline and deoxypyridinoline in urine with special attention to retaining their stability. Clin. Chem. 41:1995;571-574.
29. Schneider U., Schober E.A., Streich N.A., Breusch S.J. Urinary creatinine instability falsely increases the deoxypridinoline/creatinine quotient. Clin. Chim. Acta. 324:2002;81-88.
30. Woitge H.W., Pecherstorfer M., Li Y., Keck A.-V., Horn E., Ziegler R.et al. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. J. Bone Miner. Res. 14:1999;792-801.
31. Harris E.K. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin. Chem. 20:1974;1535-1542.
32. Harris E.K., Yasaka T. On the calculation of a 'reference change' for comparing two consecutive measurements. Clin. Chem. 29:1983;25-30.
33. Panteghini M., Pagani F. Biological variation in urinary excretion of pyridinium crosslinks: recommendations for the optimum specimen. Ann. Clin. 33:1996;36-42.
34. Robins S.P., Duncan A., Wilson N., Evans B.J. Standardization of pyridinium crosslinks, pyridinoline, and deoxypyridinoline, for use as biochemical markers of collagen degradation. Clin. Chem. 42:1996;1621-1626.
35. Anonymous Immulite Pyrilinks-D (Instructions (English)). DPC-Diagnostic Products, Los Angeles, USA.
36. Anonymous Pyrilinks-D-Immulite (Instructions (German)). DPC Biermann, Bad Nauheim, Germany.
37. Anonymous Osteomark-The NTx Test (Instructions). Ostex International, Seattle, USA.
38. Townsend J.C. Specimen preparation for microalbuminuria assay. Clin. Chem. 32:1986;559.
39. Townsend J.C. Effect of storage temperature on the precipitation of albumin from urine. Clin. Chem. 32:1986;1986-1987.
40. Silver A.C., Dawnay A., Landon J. Specimen preparation for assay of albumin in urine. Clin. Chem. 33:1987;199-200.
41. Osberg I., Chase H.P., Garg S.K., DeAndrea A., Harris S., Hamilton R.et al. Effects of storage time and temperature on measurement of small concentrations of albumin in urine. Clin. Chem. 36:1990;1428-1430.
42. Giampietro O., Cruschelli L., Penno G., Navalesi R., Clerico A. More on effects of storage time and temperature on measurement of small concentrations of albumin in urine. Clin. Chem. 37:1991;591-592.
43. Garnero P., Gineyts E., Arbault P., Christiansen C., Delmas P.D. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J. Bone Miner. Res. 10:1995;641-649.
44. Rucklidge G.J., Riddoch G.I., Williams L.M., Robins S.P. Autoradiographic studies of the renal clearance of circulating type I collagen fragments in the rat. Collagen Relat. Res. 8:1988;339-348.
45. Colwell A., Eastell R. The renal clearance of free and conjugated pyridinium cross-links of collagen. J. Bone Miner. Res. 11:1996;1976-1980.
46. Greaves R.I.N. Serum-plasma preservation. Cryobiology. 5:1968;76-86.
47. Pegg D.E. The current status of tissue cryopreservation. Cryo-Lett. 22:2001;105-114.